{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:21:59Z","timestamp":1750537319428},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1097\/md.0000000000008550","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T18:51:45Z","timestamp":1510167105000},"page":"e8550","source":"Crossref","is-referenced-by-count":3,"title":["Graves disease following radioiodine therapy for toxic adenoma"],"prefix":"10.1097","volume":"96","author":[{"given":"Guohua","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Futao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anren","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-65-20210309","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/thy.2006.16.281","article-title":"Incidence of postradioiodine immunogenic hyperthyroidism\/Graves\u2019 disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid disease","volume":"16","author":"Schmidt","year":"2006","journal-title":"Thyroid"},{"key":"R2-65-20210309","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"R3-65-20210309","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2217\/fon.14.59","article-title":"Advances in nonsurgical treatment of benign thyroid nodules","volume":"10","author":"Ha","year":"2014","journal-title":"Future Oncol"},{"key":"R4-65-20210309","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1001\/archinte.1979.03630480085027","article-title":"Graves\u2019 disease following acute (subacute) thyroiditis","volume":"139","author":"Werner","year":"1979","journal-title":"Arch Intern Med"},{"key":"R5-65-20210309","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.d01-1752.x","article-title":"Five-year follow-up of percutaneous ethanol injection for the treatment of hyperfunctioning thyroid nodules: a study of 117 patients","volume":"46","author":"Monzani","year":"1997","journal-title":"Clin Endocrinol (Oxf"},{"key":"R6-65-20210309","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF03350896","article-title":"Appearance of anti TSH-receptor antibodies and clinical Graves\u2019 disease after radioiodine therapy for hyperfunctioning thyroid adenoma","volume":"22","author":"Regalbuto","year":"1999","journal-title":"J Endocrinol Invest"},{"key":"R7-65-20210309","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1007\/s00259-004-1519-8","article-title":"Incidence of radiation-induced Graves\u2019 disease in patients treated with radioiodine for thyroid autonomy before and after introduction of a high-sensitivity TSH receptor antibody assay","volume":"31","author":"Dunkelmann","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R8-65-20210309","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1089\/thy.1997.7.535","article-title":"Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters","volume":"7","author":"Huysmans","year":"1997","journal-title":"Thyroid"},{"key":"R9-65-20210309","first-page":"2926","article-title":"Thyrotropin receptor antibodies and Graves\u2019 disease, a side-effect of 131I treatment in patients with nontoxic goiter","volume":"82","author":"Nygaard","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-65-20210309","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF03345136","article-title":"Relapses of hyperthyroidism in patients treated with radioiodine for nodular toxic goiter: relation to thyroid autoimmunity","volume":"26","author":"Custro","year":"2003","journal-title":"J Endocrinol Invest"},{"key":"R11-65-20210309","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s12020-014-0412-x","article-title":"Marine-Lenhart syndrome","volume":"49","author":"Joven","year":"2015","journal-title":"Endocrine"},{"key":"R12-65-20210309","first-page":"885","article-title":"Graves\u2019 disease with functioning nodules (Marine-Lenhart syndrome)","volume":"13","author":"Charkes","year":"1972","journal-title":"J Nucl Med"},{"key":"R13-65-20210309","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/BF03350304","article-title":"Appearance of Graves\u2019 disease after percutaneous ethanol injection for the treatment of hyperfunctioning thyroid adenoma","volume":"20","author":"Monzani","year":"1997","journal-title":"J Endocrinol Invest"},{"key":"R14-65-20210309","first-page":"444","article-title":"Graves\u2019 disease following resection of an autonomous solitary thyroid adenoma","volume":"80","author":"Freeman","year":"1983","journal-title":"J Med Soc N J"},{"key":"R15-65-20210309","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1089\/thy.1996.6.457","article-title":"The transition of subacute thyroiditis to Graves\u2019 disease as evidenced by diagnostic imaging","volume":"6","author":"Bennedbaek","year":"1996","journal-title":"Thyroid"},{"key":"R16-65-20210309","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2265.1990.tb03906.x","article-title":"Graves\u2019 disease following hypothyroidism due to Hashimoto's disease: studies of eight cases","volume":"33","author":"Takasu","year":"1990","journal-title":"Clin Endocrinol (Oxf"},{"key":"R17-65-20210309","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2169\/internalmedicine.45.1506","article-title":"Four cases of Graves\u2019 disease which developed after painful Hashimoto's thyroiditis","volume":"45","author":"Ohye","year":"2006","journal-title":"Intern Med"},{"key":"R18-65-20210309","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1507\/endocrj.42.821","article-title":"A case of repeated painless thyroiditis followed by Graves\u2019 disease","volume":"42","author":"Umena","year":"1995","journal-title":"Endocr J"},{"key":"R19-65-20210309","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2265.1992.tb02904.x","article-title":"The role of thyroid stimulating antibody (TSAb) in the thyroid function of patients with post-partum hypothyroidism","volume":"36","author":"Hara","year":"1992","journal-title":"Clin Endocrinol (Oxf"},{"key":"R20-65-20210309","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/thy.1999.9.477","article-title":"Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy","volume":"9","author":"Nygaard","year":"1999","journal-title":"Thyroid"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008550","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:40:07Z","timestamp":1620960007000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201711100-00065"}},"subtitle":["Clinical case report"],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":20,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008550","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}